Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Shattock: Novel Antigens for Mucosal Protection |
| Strategy: | Protein & peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Rabbit |
| Stage: | Assays Completed |
| Study Start Date: | 2008-12-16 |
| Study Made Public: | 2011-02-25 |
Title
Neutralization activity of sera collected from rabbits immunized with a recombinant clade C HIV gp140, formulated with various adjuvants, by the subcutaneous and intravaginal routes.
Description
CAVD 298 is a preclinical rabbit study comparing protein and adjuvant regimens administered by subcutaneous and intravaginal routes.
Sign in to see full information about this study and to download study data.
Products
ZM96 gp140Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.